GTECHPOI: G-Tech Feasibility Study for Early Detection of a Post-op Ileus

Sponsor
G-Tech Corporation (Industry)
Overall Status
Recruiting
CT.gov ID
NCT02673671
Collaborator
Eminence Clinical Research, Inc. (Industry)
150
1
82
1.8

Study Details

Study Description

Brief Summary

This feasibility study is for the purpose of determining if the G-Tech Device can differentiate between normal return of GI activity post-operatively and the myoelectric activity in patients who develop a POI.

Condition or Disease Intervention/Treatment Phase
  • Device: G-Tech Myoelectric recording device

Detailed Description

While preventing the development of a POI is most important, POIs still occur; therefore, it is important to definitively diagnose a POI as early as possible during the post-operative course for treatment to prevent patient discomfort, complications, and extended hospital stay. The purpose of the G-Tech study is to determine if the G-Tech Device can detect a difference in the myoelectric signals from patients who develop a POI compared to those patients who do not develop a POI. It is anticipated that up to 20% of patients enrolled in this study and consented preoperatively, excluding screen failures, will show evidence of a post-operative ileus as detected by the G-Tech GutCheck Device and differentiate the myoelectric signals from the patients who do not develop a POI. Patients who are known to have developed a POI may also be selected for the study.

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Measurement Of GI Myoelectric Activity In Patients At Risk For Or Who Have A Post-Operative Ileus (POI) - Monitoring/ Recording GI Myoelectric Activity For Early Detection of A POI
Study Start Date :
Feb 1, 2016
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Subjects with unknown POI status consented pre-surgery

Up to 100 subjects may be consented prior to surgery who are planned to undergo gastrointestinal surgery or a planned surgery that does not involve the abdominal cavity. The investigator does not change the routine medical care of study participants.

Device: G-Tech Myoelectric recording device
A minimum of three patches are placed on the abdomen of the patient to record myoelectric activity.
Other Names:
  • Gastro-intestinal electrical recording
  • Subjects with known/unknown POI status consented post-surgery

    Up to 50 subjects who have undergone gastrointestinal surgery or surgery not involving the abdominal cavity may be consented post- operatively during their hospital stay for this study.The investigator does not change the routine medical care of study participants.

    Device: G-Tech Myoelectric recording device
    A minimum of three patches are placed on the abdomen of the patient to record myoelectric activity.
    Other Names:
  • Gastro-intestinal electrical recording
  • Outcome Measures

    Primary Outcome Measures

    1. Myoelectric activity pattern in POI patients versus non-POI patients [Up to 6 Days]

      The resumption of motor activity in the stomach, small intestine, and colon post-operatively. The measurement is myoelectric signals measured at the skin surface similar to ECG recordings for the heart

    Secondary Outcome Measures

    1. Anticipated Adverse Events [Up to 6 days]

      Device related anticipated adverse events; such as, skin irritation due to adhesive from the skin patch.

    2. UADEs [Up to 6 Days]

      Unanticipated adverse device effects

    3. Device Success [Up to 6 Days]

      Device success defined as the ability to record GI myoelectric activity following GI surgery.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Willing and able to provide informed consent;

    2. Eighteen (18) years of age or older;

    3. Subject is willing and able to follow all study requirements;

    4. Subject who will undergo or has undergone open or laparoscopic gastrointestinal surgery or surgery not involving the abdominal cavity.

    Exclusion Criteria:
    1. Subject is pregnant or suspects pregnancy;

    2. Known allergy to medical grade adhesive;

    3. Weight > 350 lbs (159 Kg);

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 El Camino Hospital Mountain View California United States 94040

    Sponsors and Collaborators

    • G-Tech Corporation
    • Eminence Clinical Research, Inc.

    Investigators

    • Principal Investigator: George Triadafilopoulos, MD, El Camino GI Medical Associates

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    G-Tech Corporation
    ClinicalTrials.gov Identifier:
    NCT02673671
    Other Study ID Numbers:
    • CLP-2014-001
    First Posted:
    Feb 4, 2016
    Last Update Posted:
    Feb 18, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 18, 2022